| Symbol | BWAY |
|---|---|
| Name | BRAINSWAY LTD. |
| Sector | HEALTH CARE |
| Region | Asia |
| Industry | - |
| Address | 9777518 Israel 19 Hartum St. Bynet Building, 3rd Floor Har Hotzvim, |
| Telephone | (+972-2) 582-4030 |
| Fax | 02-5812517 |
| hadarl@brainsway.com | |
| Website | http://www.brainsway.com |
| Incorporation | IL |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;TASE;NASDAQ |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001505065 |
| Description | BrainsWay is dedicated to developing and providing advanced technology solutions for the treatment of a variety of brain disorders. The company was established in 2003, and became a public company traded on the Tel-Aviv Stock Exchange in January 2007. BrainsWays flagship technology is Deep-TMS, or Deep Transcranial Magnetic Stimulation, which launches a new era in brain disorder treatment. Additional info from NASDAQ: Additional info from OTC: |
BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026
Read moreNew Form SCHEDULE 13G/A - Brainsway Ltd. <b>Filed:</b> 2026-07-29 <b>AccNo:</b> 0001178913-26-003637 <b>Size:</b> 9 KB
Read moreBrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder
Read moreBrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder
Read moreMoiseyev Gilad 🟡 adjusted position in 6.9K shares (1 derivative) of Brainsway Ltd. (BWAY) Transaction Date: May 25, 2026 | Filing ID: 004216
Read more